- Special Report - Peak Performance: Challenges and Opportunities in Post COVID-19 Credit Fund Platforms
- Event: Navigating Life Sciences M&A Under the Biden Administration | Drug Pricing & Antitrust Considerations (March 25, 2021)
- Event: Outlook 2021 – Washington, D.C. Updates and Insights on Life Sciences and Health Care (February 25, 2021)
- In Law360, Margaux Hall Examines Drug Commercialization and Market Access Strategies in Light of Drug Pricing Regulatory Uncertainty Under the Biden Administration
(February 16, 2021)
- FTC, DOJ Announce Suspension of HSR Early Termination
(February 8, 2021)
- Private Funds Report, Volume 1 – 2020 Year in Review And A Look Ahead
(January 29, 2021)
- Bipartisan Proposal for Extension and Revision of Coronavirus Aid, Relief, and Economic Security Act (CARES Act) – Summary of Key Provisions
(January 27, 2021)
- In Law360, Attorneys Evaluate 2021 IPO Market
(January 5, 2021)
- In Law360 Tom Bulleit Analyzes 2021 Health Policies Under the Biden Administration
(January 5, 2021)
- Phase 4 Stimulus Package—Highlight of Certain Key Tax-Related Provisions in the Phase 4 Stimulus Package
(December 22, 2020)
- Ropes & Gray Partners Discuss ESG In The Wall Street Journal Pro Private Equity
(December 18, 2020)
- Video: 2020 Election and Health Care
(December 15, 2020)
- ERISA Partner Josh Lichtenstein Quoted in Press on the Labor Department’s Final ESG Rule
(November 19, 2020)
Cookie Settings
